BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17497299)

  • 1. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.
    Wu Y; Liu H; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):206-8. PubMed ID: 17497299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
    Oh CW; Penneys N
    Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.
    Muehleisen B; Schaerer L; Dummer R; Burg G; Hofbauer GF
    J Cutan Pathol; 2007 Jan; 34(1):1-6. PubMed ID: 17214847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of cyclooxygenase-2 in skin tumors.
    Amirnia M; Babaie-Ghazani A; Fakhrjou A; Khodaeiani E; Alikhah H; Naghavi-behzad M; Zarrintan A
    J Dermatolog Treat; 2014 Oct; 25(5):380-7. PubMed ID: 22667343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
    Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
    Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
    Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
    Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
    Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
    Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions.
    Mitsuishi T; Kawana S; Kato T; Kawashima M
    Hum Pathol; 2003 Sep; 34(9):886-92. PubMed ID: 14562284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
    Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.